| scholarly article | Q13442814 |
| P50 | author | Charles N Serhan | Q87981947 |
| P2093 | author name string | Sean P Colgan | |
| Makoto Arita | |||
| Geraldine O Canny | |||
| Nancy A Louis | |||
| Eric L Campbell | |||
| Sarah E Tomassetti | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 3162-3170 | |
| P577 | publication date | 2007-05-11 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution | |
| P478 | volume | 21 |
| Q38008342 | Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair |
| Q91620774 | Adaptation to inflammatory acidity through neutrophil-derived adenosine regulation of SLC26A3 |
| Q43007771 | Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin |
| Q35995535 | Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators |
| Q26784433 | Biological Roles of Resolvins and Related Substances in the Resolution of Pain |
| Q39271007 | Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation |
| Q43198306 | Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. |
| Q34456020 | Chemerin/chemR23 axis in inflammation onset and resolution |
| Q34629210 | Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties |
| Q51617434 | Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. |
| Q33719500 | Contributions of neutrophils to resolution of mucosal inflammation |
| Q38126487 | Control of neutrophil inflammation at mucosal surfaces by secreted epithelial products |
| Q33356900 | Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators |
| Q28269550 | DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation |
| Q33631285 | Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease |
| Q38169805 | Dietary modulation of the inflammatory cascade |
| Q41554270 | Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study |
| Q26778011 | Eicosanoid pathway in colorectal cancer: Recent updates |
| Q38082485 | Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis |
| Q28249435 | Emerging roles of resolvins in the resolution of inflammation and pain |
| Q90236775 | Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys |
| Q37191369 | Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders |
| Q31134484 | Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus |
| Q91921361 | Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes |
| Q35861333 | In vivo visualization of skin inflammation by optical coherence tomography and two-photon microscopy |
| Q38902578 | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair |
| Q58728070 | Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control |
| Q44181781 | Information generation and processing systems that regulate periodontal structure and function. |
| Q34465047 | Innate immunity is a key factor for the resolution of inflammation in asthma |
| Q38268617 | Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity |
| Q38186066 | Intestinal alkaline phosphatase: novel functions and protective effects |
| Q34025186 | Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway |
| Q38089177 | Lipoxins, resolvins and protectins: new leads for the treatment of asthma |
| Q38451839 | Mcl-1 is vital for neutrophil survival. |
| Q38916635 | Microglia and Monocyte-Derived Macrophages in Stroke |
| Q38091028 | Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins |
| Q84561409 | Molecular circuits of resolution in airway inflammation |
| Q36981038 | NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A |
| Q40403668 | Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes |
| Q38079492 | Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). |
| Q34982051 | Novel anti-inflammatory--pro-resolving mediators and their receptors |
| Q33683210 | Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? |
| Q37233208 | Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins |
| Q41830016 | Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis? |
| Q41881526 | PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. |
| Q52369219 | Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. |
| Q36953771 | Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts |
| Q38655581 | Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review |
| Q37039920 | Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis |
| Q38899898 | Regulation of inflammation by lipid mediators in oral diseases |
| Q33882297 | Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss |
| Q28652204 | Resolution of acute inflammation in the lung |
| Q26823724 | Resolution of inflammation in asthma |
| Q92715753 | Resolution of inflammation in periodontitis: a review |
| Q38054089 | Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications |
| Q28249812 | Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 |
| Q37142408 | Resolvin D1 protects periodontal ligament |
| Q42197506 | Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis |
| Q41436308 | Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis |
| Q36236176 | Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation |
| Q30493174 | Resolvin E1 receptor activation signals phosphorylation and phagocytosis |
| Q37445402 | Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation |
| Q34069514 | Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. |
| Q29615694 | Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators |
| Q37447457 | Resolvins and protectins: mediating solutions to inflammation |
| Q37708842 | Resolvins and protectins: natural pharmacophores for resolution biology |
| Q37362056 | Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives |
| Q34448487 | Resolvins: natural agonists for resolution of pulmonary inflammation. |
| Q57165511 | Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction |
| Q37947960 | Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer |
| Q28244502 | Roles of resolvins in the resolution of acute inflammation |
| Q39148416 | Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses |
| Q88540273 | Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases |
| Q33657562 | Specialized pro-resolving lipid mediators in the inflammatory response: An update |
| Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
| Q35098090 | Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution |
| Q33384350 | Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators |
| Q28080144 | The Dual Role of Neutrophils in Inflammatory Bowel Diseases |
| Q34400164 | The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury |
| Q34482353 | The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection |
| Q37110369 | The inflammatory tissue microenvironment in IBD. |
| Q35216463 | The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats |
| Q38001546 | The role of neutrophils during intestinal inflammation |
| Q33949950 | The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease |
| Q36805449 | The α-tocopherol form of vitamin E reverses age-associated susceptibility to streptococcus pneumoniae lung infection by modulating pulmonary neutrophil recruitment |
| Q28068273 | Transition from inflammation to proliferation: a critical step during wound healing |
| Q38093013 | Understanding resolvin signaling pathways to improve oral health |
| Q39504951 | Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device |
Search more.